An A1cNOW+ is a single-use, disposable, and reimbursable point-of-care fingerstick blood test that measures diabetes (Prediabetes, Diabetes, and Gestational) in 5-minutes from an average blood glucose level over the past 3-months. 

 Reimbursement for A1C Testing

Step 1: Submit an application to apply for a CLIA Certificate of Waiver

The first step in receiving any Medicare reimbursement is to obtain a CLIA Certificate of Waiver. The physician’s office or laboratory will need to pay a fee to the Centers for Medicare and Medicaid Services (CMS) every two years and agree to follow the device manufacturer’s instructions for performing clinical tests.

Step 2: Submit the Appropriate CPT Codes

The following Current Procedural Terminology (CPT) codes are suggested for submitting tests performed with PTS Diagnostics products for Medicare and Medicaid reimbursement. These are suggested codes.

83036 QW — For professional use in the management of diabetes mellitus where regular determinations of blood glucose levels are required.  Glycated hemoglobin assesses glycemic control over a period of approximately 120 days ($13 average)

36416 — Collection of capillary blood (Fingerstick) specimen ($3 average)

A Value-Based Resource